Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novo Nordisk A/S
  6. News
  7. Summary
    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe Europe - 12/09 03:27:03 am
741.85 DKK   +0.44%
12/07NOVO NORDISK : Deutsche Bank reaffirms its Buy rating
MD
12/07NOVO NORDISK : Jefferies reiterates its Sell rating
MD
12/03European ADRs Move Sharply Lower in Friday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about NOVO NORDISK A/S
12/07NOVO NORDISK : Deutsche Bank reaffirms its Buy rating
MD
12/07NOVO NORDISK : Jefferies reiterates its Sell rating
MD
11/29Novo Nordisk A/S – Share repurchase programme
AQ
11/29NOVO NORDISK : Deutsche Bank reaffirms its Buy rating
MD
11/26Novo Nordisk Secures Canadian Approval for Weight Loss Drug Wegovy
MT
11/26NOVO NORDISK : Gets a Neutral rating from UBS
MD
11/26NOVO NORDISK : JP Morgan gives a Buy rating
MD
11/26NOVO NORDISK : Bernstein remains its Buy rating
MD
11/26Novo Nordisk says lower insulin prices in China dent 2022 outlook
RE
11/26Novo Nordisk Projects 3% Decline in 2022 Sales on Lower Insulin Sales in China
MT
11/26Novo Nordisk Expects Lower Insulin Prices, Volumes in China to Dent FY22 Global Sales
MT
11/26Novo Nordisk announces impact from Volume Based Procurement for insulin in China
AQ
11/25Novo Nordisk Announces Health Canada Approves Wegovy? for the Treatment of Adults with ..
CI
11/22NOVO NORDISK : Barclays reiterates its Buy rating
MD
11/19NOVO NORDISK : UBS sticks Neutral
MD
More most relevant news
All news about NOVO NORDISK A/S
12/07NOVO NORDISK : Deutsche Bank reaffirms its Buy rating
MD
12/07NOVO NORDISK : Jefferies reiterates its Sell rating
MD
12/03European ADRs Move Sharply Lower in Friday Trading
MT
12/03Drugmakers cut prices by 62% on average to get China state insurance listing
RE
11/29Novo Nordisk A/S – Share repurchase programme
AQ
11/29NOVO NORDISK : Deutsche Bank reaffirms its Buy rating
MD
11/26Novo Nordisk Secures Canadian Approval for Weight Loss Drug Wegovy
MT
11/26NOVO NORDISK : Gets a Neutral rating from UBS
MD
11/26NOVO NORDISK : JP Morgan gives a Buy rating
MD
11/26NOVO NORDISK : Bernstein remains its Buy rating
MD
More news
News in other languages on NOVO NORDISK A/S
12/03Les ADR européens en forte baisse dans la négociation de vendredi
11/26DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 26.11.2021 - 15.15 Uhr
11/26Novo Nordisk obtient l'approbation canadienne pour le médicament de perte de poids Wego..
11/26MIDDAY BRIEFING - Unternehmen und Märkte -2-
11/26AKTIEN EUROPA : Neue Coronavirus-Variante schlägt Anleger in die Flucht
11/26NOVO NORDISK : Oddo maintient son conseil sur le titre
11/26Novo Nordisk estime que la baisse des prix de l'insuline en Chine compromet les perspec..
11/26Novo Nordisk prévoit une baisse de 3 % de son chiffre d'affaires en 2022 en raison de l..
11/26NIEDRIGERE INSULINPREISE IN CHINA : Novo Nordisk rechnet mit Bremseffekt
11/26Novo Nordisk von niedrigeren Insulin-Preisen in China belastet
More news
Analyst Recommendations on NOVO NORDISK A/S
12/07NOVO NORDISK : Deutsche Bank reaffirms its Buy rating
MD
12/07NOVO NORDISK : Jefferies reiterates its Sell rating
MD
11/29NOVO NORDISK : Deutsche Bank reaffirms its Buy rating
MD
11/26NOVO NORDISK : Gets a Neutral rating from UBS
MD
11/26NOVO NORDISK : JP Morgan gives a Buy rating
MD
More recommendations
Press releases
11/29Novo Nordisk A/S – Share repurchase programme
AQ
11/26Novo Nordisk announces impact from Volume Based Procurement for insulin in China
AQ
11/17PharmStars Announces Showcase Event for Inaugural Class
AQ
11/15Novo Nordisk A/S – Share repurchase programme
AQ
11/12Ozempic® 2.0 mg recommended for approval for the treatment of type 2 diabetes by the Eu..
AQ
More press releases
Upcoming event on NOVO NORDISK A/S